Skip to Content

4Front Ventures Corp FFNT

Morningstar Rating
CAD 0.14 0.01 (3.57%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FFNT is trading at a 38% discount.
Price
CAD 0.14
Fair Value
CAD 2.81
Uncertainty
Extreme
1-Star Price
CAD 9.24
5-Star Price
CAD 8.73
Economic Moat
Zktg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FFNT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 0.14
Day Range
CAD 0.140.15
52-Week Range
CAD 0.090.40
Bid/Ask
CAD 0.12 / CAD 0.15
Market Cap
CAD 123.42 Mil
Volume/Avg
23,000 / 108,677

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.69
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
699

Comparables

Valuation

Metric
FFNT
CL
VRNO
Price/Earnings (Normalized)
Price/Book Value
1.471.54
Price/Sales
0.690.901.99
Price/Cash Flow
16.0417.00
Price/Earnings
FFNT
CL
VRNO

Financial Strength

Metric
FFNT
CL
VRNO
Quick Ratio
0.110.780.52
Current Ratio
0.341.390.96
Interest Coverage
−4.76−1.361.46
Quick Ratio
FFNT
CL
VRNO

Profitability

Metric
FFNT
CL
VRNO
Return on Assets (Normalized)
−10.78%−3.12%−2.28%
Return on Equity (Normalized)
−8.02%−4.10%
Return on Invested Capital (Normalized)
−11.21%−0.11%−0.53%
Return on Assets
FFNT
CL
VRNO
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AFpxhqmcjcJvqz$70.0 Bil
MKKGY
Merck KGaA ADRBtmlsycqkGpbgzrt$67.6 Bil
HLN
Haleon PLC ADRDtmrkbnfwBhv$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXqxmwdwGshly$14.3 Bil
VTRS
Viatris IncPwmwnrwpjNgq$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHbmyqcxqhJqb$11.9 Bil
CTLT
Catalent IncMhjrylhcmXzptdxx$10.0 Bil
PRGO
Perrigo Co PLCVltdxvwRmmdp$4.1 Bil
CURLF
Curaleaf Holdings IncNqkxtjzkrNtr$3.6 Bil
PBH
Prestige Consumer Healthcare IncYdnlwzzzxKvhzcm$3.4 Bil

Sponsor Center